Wang S, Venkatraman V, Crowgey E, Liu T, Fu Z, Holewinski R
Circ Res. 2018; 122(11):1517-1531.
PMID: 29563102
PMC: 6047766.
DOI: 10.1161/CIRCRESAHA.118.312789.
Dai H, Wang M, Patel P, Kalogeris T, Liu Y, Durante W
Am J Physiol Heart Circ Physiol. 2017; 313(5):H988-H999.
PMID: 28822969
PMC: 5792206.
DOI: 10.1152/ajpheart.00620.2016.
Foster M, Coetzee W
Physiol Rev. 2015; 96(1):177-252.
PMID: 26660852
PMC: 4698399.
DOI: 10.1152/physrev.00003.2015.
Zhang Q, Yuan W, Wang G, Wu J, Wang M, Li C
Crit Care. 2014; 18(6):641.
PMID: 25475018
PMC: 4262990.
DOI: 10.1186/s13054-014-0641-7.
Ay Y, Aydin C, Basel H, Bektas H, Bulut G, Inan B
J Membr Biol. 2013; 246(6):473-8.
PMID: 23673724
PMC: 3682096.
DOI: 10.1007/s00232-013-9559-2.
Analysis of the influences of short-term levosimendan exposure on oxidant/antioxidant status and trace-element levels in the physiological status of the thoracic aorta of rats.
Aydin C, Ay Y, Basel H, Kavak S, Inan B, Bektas H
J Membr Biol. 2012; 245(12):827-32.
PMID: 22843162
DOI: 10.1007/s00232-012-9489-4.
Adenosine A(1) and A (3) receptor agonists reduce hypoxic injury through the involvement of P38 MAPK.
Leshem-Lev D, Hochhauser E, Chanyshev B, Isak A, Shainberg A
Mol Cell Biochem. 2010; 345(1-2):153-60.
PMID: 20730620
DOI: 10.1007/s11010-010-0568-5.
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.
Juhaszova M, Zorov D, Kim S, Pepe S, Fu Q, Fishbein K
J Clin Invest. 2004; 113(11):1535-49.
PMID: 15173880
PMC: 419483.
DOI: 10.1172/JCI19906.
Efficacy of preconditioning should be gauged by reduction of infarction.
Cohen M
Br J Pharmacol. 2004; 141(2):197-8.
PMID: 14751867
PMC: 1574199.
DOI: 10.1038/sj.bjp.0705612.
Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels.
Hanley P, Gopalan K, Lareau R, Srivastava D, von Meltzer M, Daut J
J Physiol. 2003; 547(Pt 2):387-93.
PMID: 12562916
PMC: 2342646.
DOI: 10.1113/jphysiol.2002.037044.
Cardioselectivity of the sulphonylurea HMR 1098: studies on native and recombinant cardiac and pancreatic K(ATP) channels.
Manning Fox J, Kanji H, French R, Light P
Br J Pharmacol. 2002; 135(2):480-8.
PMID: 11815384
PMC: 1573135.
DOI: 10.1038/sj.bjp.0704455.
Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle.
Chutkow W, Samuel V, Hansen P, Pu J, Valdivia C, Makielski J
Proc Natl Acad Sci U S A. 2001; 98(20):11760-4.
PMID: 11562480
PMC: 58803.
DOI: 10.1073/pnas.201390398.
